Gene products differentially expressed in cancerous cells and their methods of use II
US8101349B2 · kind B2 · utility
16Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 12, 2004 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Dec 20, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.